Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
management interviews
Jump to
9 Results Found
  • Here's what Cadila has to say about US price erosion concerns Feb 23, 2018 05:43 PM IST

    Here's what Cadila has to say about US price erosion concerns

    The Indian Pharmaceutical Alliance's (IPA) quality forum is currently underway in Hyderbad. CNBC-TV18’s Arachana Shukla caught up with the Managing Director of Cadila Healthcare, Sharvil Patel on the sidelines of that forum and asked him about price erosion in the US market.

  • TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study Dec 08, 2017 12:19 PM IST

    TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study

    Ajanta Pharma retains the tag of fastest wealth creator for the third time in a row and Asian Paints is the most consistent wealth creator, said the wealth creation study

  • Want to significantly expand emerging market business: Cadila Oct 05, 2017 02:36 PM IST

    Want to significantly expand emerging market business: Cadila

    In a rare television appearance, Cadila Healthcare's relatively new Managing Director, Sharvil Patel spoke with CNBC-TV18's Ekta Batra on a whole host of issues including their hope of becoming India's number one oncology player within the next 5 years.

  • Aim to develop and market molecules in India first: Zydus Cadila Feb 03, 2017 09:51 AM IST

    Aim to develop and market molecules in India first: Zydus Cadila

    In an interview with CNBC-TV18, Pankaj R Patel, CMD, Zydus Cadila Healthcare, talked about the company's business strategy, progress with molecule research and earnings outlook.

  • Pricing pressure in US biz cyclical in nature: Cadila Health Oct 15, 2016 01:00 PM IST

    Pricing pressure in US biz cyclical in nature: Cadila Health

    In an exclusive interview with CNBC-TV18, Pankaj Patel said that the pricing pressure in US is cyclical in nature and competition is going to exist in the generic medicine market in US.

  • Indian pharma cos need to step-up safeguards at plants: Handa Mar 29, 2016 09:29 PM IST

    Indian pharma cos need to step-up safeguards at plants: Handa

    In the last five months, plants of nine Indian pharmaceutical companies - Cipla, Dr Reddy‘s, Sun Pharma, Cadila, Lupin and Natco Pharma.- have come under the US Food and Drug Administration (FDA) scanner.

  • No data integrity issue at Moraiya facility: Cadila Health Dec 31, 2015 02:34 PM IST

    No data integrity issue at Moraiya facility: Cadila Health

    Pankaj R Patel, CMD, Cadila Healthcare, said there are no data integrity issues with the Moraiya facility. He said the company plans to give additional information to the US FDA to address the Moraiya issue

  • Indian pharma to revive by Apr; see better margins: Cadila Jan 14, 2014 11:46 AM IST

    Indian pharma to revive by Apr; see better margins: Cadila

    However, increased inspection is a positive for the industry, opines Pankaj R Patel, chairman and managing director, Zydus Cadila Healthcare. This, despite the fact that the company has received a warning letter from the US regulator.

  • Zydus Cadila to launch Lipaglyn in other mkts in 3-5 yrs Jun 07, 2013 10:53 AM IST

    Zydus Cadila to launch Lipaglyn in other mkts in 3-5 yrs

    Cadila's CMD Pankaj Patel says global market size for Lipaglyn type of drug is around USD 29 billion. The drug is expected to be launched in India in Q3 and in other markets in 3-5 years.

Sections